Last reviewed · How we verify
Placebo normal saline PENG block
Normal saline placebo serves as an inert control in the PENG (Pectoral Nerves) block study, providing no active pharmacological effect.
Normal saline placebo serves as an inert control in the PENG (Pectoral Nerves) block study, providing no active pharmacological effect. Used for Control arm in PENG block clinical trial for regional anesthesia.
At a glance
| Generic name | Placebo normal saline PENG block |
|---|---|
| Also known as | Placebo Pericapsular Nerve Group block |
| Sponsor | University of California, San Diego |
| Modality | Small molecule |
| Therapeutic area | Anesthesia/Pain Management |
| Phase | FDA-approved |
Mechanism of action
This is a saline control arm in a clinical trial evaluating the PENG (Pectoral Nerves) block, a regional anesthesia technique. The placebo saline injection mimics the procedural intervention without delivering active anesthetic agents, allowing researchers to isolate the true efficacy of the nerve block procedure itself from placebo effects.
Approved indications
- Control arm in PENG block clinical trial for regional anesthesia
Common side effects
Key clinical trials
- PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults (NA)
- The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty: (NA)
- Effectiveness of PENG Block Combined to LFCN Block on the Quality of Recovery After Total Hip Replacement (NA)
- PENG Block for Total Hip Arthroplasty (PHASE4)
- Pericapsular Nerve Group Block (PENG) for Hip Surgery (PHASE4)
- PENG Block for Arthroscopic Hip Surgery (NA)
- Pericapsular Nerve Group Block for Elective Hip Arthroplasty (NA)
- Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: